State Of Alaska, Department Of Revenue Organogenesis Holdings Inc. Transaction History

State Of Alaska, Department Of Revenue

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	BUY	$2.48 - $3.43 $726 - $1,004	293 Added 0.6%	49,226 $132,000
Q3 2022 Oct 20, 2022	BUY	$3.14 - $6.43 $14,547 - $29,790	4,633 Added 10.46%	48,933 $158,000
Q2 2022 Jul 08, 2022	BUY	$4.74 - $8.15 $2,133 - $3,667	450 Added 1.03%	44,300 $216,000
Q1 2022 Apr 14, 2022	SELL	$6.47 - $9.57 $5,046 - $7,464	-780 Reduced 1.75%	43,850 $334,000
Q4 2021 Jan 12, 2022	SELL	$9.02 - $13.5 $11,455 - $17,145	-1,270 Reduced 2.77%	44,630 $412,000
Q3 2021 Oct 07, 2021	BUY	$13.71 - $17.18 $154,923 - $194,134	11,300 Added 32.66%	45,900 $653,000
Q2 2021 Jul 12, 2021	BUY	$14.92 - $23.23 $516,232 - $803,758	34,600 New	34,600 $575,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $408M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.